Hogy Medical cuts fiscal 2026 earnings outlook amid challenging environment
Hogy Medical has revised its consolidated financial forecasts for the fiscal year ending March 2026. For the second quarter (April 1 to September 30, 2025), net sales are now projected at JPY 18,857 million, down from the initial JPY 20,170 million. Operating profit is expected to decrease by 30.6% to JPY 1,277 million, and net profit attributable to parent company shareholders is forecast at JPY 907 million, a 30.2% reduction.
The full-year consolidated forecast (April 1, 2025 to March 31, 2026) also reflects a downward adjustment. Net sales are revised to JPY 39,240 million from JPY 41,790 million. Operating profit is now projected at JPY 2,770 million, representing a 35.6% decrease, while net profit attributable to parent company shareholders is expected to be JPY 2,030 million, a 32.8% reduction.
The company attributed these revisions to a challenging medical environment, including rising costs and increased competition. Despite a projected increase in sales in the latter half of the year, the second quarter's underperformance could not be fully recovered. The company aims to continue its mid-term management plan and structural reforms, with no changes to its dividend forecast.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Hogy Medical publishes news
Free account required • Unsubscribe anytime